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Panx1 Regulates Cellular Properties of Keratinocytes
and Dermal Fibroblasts in Skin Development and
Wound Healing
Silvia Penuela1, John J. Kelly1, Jared M. Churko1,3, Kevin J. Barr2, Amy C. Berger2 and Dale W. Laird1,2
Pannexin1 (Panx1), a channel-forming glycoprotein is expressed in neonatal but not in aged mouse skin.
Histological staining of Panx1 knockout (KO) mouse skin revealed a reduction in epidermal and dermal thickness
and an increase in hypodermal adipose tissue. Following dorsal skin punch biopsies, mutant mice exhibited a
significant delay in wound healing. Scratch wound and proliferation assays revealed that cultured keratinocytes
from KO mice were more migratory, whereas dermal fibroblasts were more proliferative compared with controls.
In addition, collagen gels populated with fibroblasts from KO mice exhibited significantly reduced contraction,
comparable to WT fibroblasts treated with the Panx1 blocker, probenecid. KO fibroblasts did not increase a-
smooth muscle actin expression in response to TGF-b, as is the case for differentiating WTmyofibroblasts during
wound contraction. We conclude that Panx1 controls cellular properties of keratinocytes and dermal fibroblasts
during early stages of skin development and modulates wound repair upon injury.
Journal of Investigative Dermatology (2014) 134, 2026–2035; doi:10.1038/jid.2014.86; published online 27 March 2014
INTRODUCTION
The channel-forming family of glycoproteins, known as
pannexins, consists of three members: Panx1, Panx2, and
Panx3 (Panchin et al., 2000). Although all three pannexins
form functional single-membrane channels (Penuela et al.,
2009), Panx1, which is the most ubiquitously expressed of the
three (Baranova et al., 2004), has been more extensively
studied (Penuela et al., 2013). The role of Panx1 as a
mechanosensitive ATP-release channel (Bao et al., 2004) has
been linked to paracrine signaling involving Ca2þ wave
propagation (Locovei et al., 2006), vasoconstriction (Billaud
et al., 2011), airway defense (Seminario-Vidal et al., 2011),
and even facilitating HIV viral infection (Seror et al., 2011).
Panx1 has also been shown to mediate cellular responses in
the immune system, acting as the ATP-release channel of
‘find-me’ signals from apoptotic cells to monocytes during
their recruitment for cell clearance (Chekeni et al., 2010).
Under pathological conditions, Panx1 has been reported to
increase the severity of seizures in status epilepticus (Santiago
et al., 2011). Panx1 channel opening increases neuronal cell
death under ischemic conditions (Thompson et al., 2006,
2008), and promotes death of enteric neurons in colitis
(Gulbransen et al., 2012).
In normal development, all three pannexins have been
reported to have an important role in different cell types.
Panx1 is important in differentiation of keratinocytes
(Celetti et al., 2010), Panx3 in osteoblasts (Bond et al., 2011;
Ishikawa et al., 2011) and chondrocytes (Iwamoto et al., 2010;
Bond et al., 2011), and Panx2 in development of neuronal
cells (Swayne et al., 2010). Panx1 has been implicated in the
differentiation of cardiac fibroblasts into myofibroblasts in
response to ATP released from cardiomyocytes (Dolmatova
et al., 2012). Recently, it was also reported that mast cell–
derived histamine can activate ATP release from human
subcutaneous fibroblasts via Panx1 channels through H1
receptor activation (Pinheiro et al., 2013). Interestingly,
Panx1 is not only functional at the cell surface but has also
been shown to be expressed in intracellular compartments,
such as the endoplasmic reticulum, where it is proposed to
function as an intracellular Ca2þ leak channel (Vanden
Abeele et al., 2006; D’Hondt et al., 2011).
In adult human skin, we have previously reported the
expression of Panx1 and Panx3 in the different layers and
appendages of the skin with various localization profiles
(Penuela et al., 2007; Cowan et al., 2012). In mouse skin,
we detected Panx1 and Panx3 expression as early as day
E13.5 in the developing epidermis and dermis (Celetti et al.,
2010). At the cellular level, we demonstrated that an
overexpression of Panx1 in rat epidermal keratinocytes
(REKs) reduced their proliferation rate, and disrupted their
normal differentiation in a model of organotypic epidermis
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grown in three-dimensional cultures from these engineered
REKs (Celetti et al., 2010). In addition, Panx1 expression in basal
and squamous skin cell carcinomas, as well as in the more
deadly melanomas, has been shown to change with malignant
transformation of the skin. In human keratinocyte tumors, both
Panx1 and Panx3 are significantly reduced (Cowan et al., 2012),
whereas mouse melanomas express high levels of Panx1 that
can be downregulated to revert them into a more normal
melanocytic phenotype (Penuela et al., 2012).
Using the Panx1 knockout (KO) mouse model reported
by Qu et al. (2011), we set out to evaluate the role of Panx1
in skin development and response to injury in vivo.
We discovered that Panx1 is necessary for early skin
development, has decreasing expression in aged skin, and is
upregulated again upon wounding. Panx1 has a role in the
migration of keratinocytes and regulates differentiation of
dermal fibroblasts into myofibroblasts for proper wound
contraction. When Panx1 is missing, fibroblasts proliferate
more and do not properly differentiate in response to TGF-b,
leading to the formation of fibrotic scars.
RESULTS
Panx1 expression decreases in aging dorsal skin
Levels of endogenous Panx1 protein expression in the dorsal
skin of neonatal mice and in mice up to 4 weeks of age were
higher than those in adult mice (12 weeks old) and in aged
mice of up to 18 months (Figure 1a). This same trend was
observed in studies using Panx1 immunofluorescence labeling
of skin sections of different ages (Figure 1b and c). Panx1 is
localized at the cell surface of basal keratinocytes and hair
follicles of neonatal skin (Figure 1b, white arrowheads),
whereas dermal fibroblasts and differentiated keratinocytes
of the upper layers of the epidermis present an intracellular
distribution (Figure 1b, stars and open arrowheads). As the
skin ages, Panx1 not only decreases in the different layers of
the skin, but its localization pattern is less prevalent at the cell
surface of the different skin cell types (Figure 1c).
Characterization of the Panx1 KO mouse model
As previously described and characterized by Qu et al. (2011),
a gene-targeting strategy was used to generate Panx1-null
mice that were confirmed to lack Panx1 in tissues in which
expression is normally abundant, such as the brain, thymus,
and spleen (Figure 1d and e). Neonatal dorsal skin of the
Panx1 KO was also devoid of Panx1. To verify the absence of
any Panx1 transcript in the KO mouse, brain and thymus
tissue from WT and KO mice were used for qPCR of Panx1
(Figure 1e). Panx1 is absent in KO mice dorsal skin (Figure 1f),
whereas Panx3 was found to be upregulated in young and
adult Panx1 KO skin compared with controls (Figure 1g).
Decreased dermal thickness and increased hypodermal fat in
Panx1 KO mice
Panx1 KO mice are viable, fertile, and do not show an overt
skin phenotype. However, comparing histological sections of
dorsal skin from 1-day to 7-week-old WT mice with those
from KO mice, we detected a significant decrease in total
dermal area (dermis and epidermis) of KO dorsal skin in every
age group. At the same time, the hypodermal fat area was
significantly increased in the KO mice as early as 4 days after
birth and this trend prevailed into adulthood (Figure 2).
Panx1 is upregulated in dorsal skin wounds and its depletion
delays wound healing, increasing fibrosis
Healing of dorsal wounds on 12-week-old males was sig-
nificantly reduced in KO mice compared with that in WT
controls at every stage of healing, including inflammation,
proliferation, and tissue remodeling (Figure 3a). Although
wounds eventually closed, there was a prominent scar on
the KO mouse skin, which when examined in histological
sections revealed an area of increased fibrosis (Figure 3b) that
was quantified by measuring the maximum wound depth
(N¼ 4, n¼ 12, Po0.01).
As mentioned before, mouse dorsal skin at 12 weeks of age
has low basal levels of Panx1 expression (Figure 1c). How-
ever, upon wounding, Panx1 expression detected by immu-
nohistochemistry is increased near the site of the wound as
early as 3 days after surgery in WT dorsal skin (Figure 3c).
Panx1 is apparent in both dermis and epidermis, reaching
maximum expression at day 6 after surgery. By day 13, Panx1
protein expression returns to basal levels around the wound
site, but it is still highly expressed in the new re-epithelialized
tissue (above dotted wound line, Figure 3c).
Primary basal keratinocytes express high levels of Panx1 in early
stages of differentiation
To elucidate the mechanism responsible for delayed wound
healing in KO mice skin, we isolated primary keratinocytes
from neonatal dorsal skin. WT basal keratinocytes are
enriched in Panx1 (Figure 4a). A growth curve assay showed
no significant differences in the growth rate of KO keratino-
cytes compared with that in WT controls (Figure 4b). How-
ever, an in vitro scratch wound assay revealed a significantly
dysregulated migration/proliferation of KO keratinocytes after
12 hours of migration in the presence of serum (Figure 4c). To
test for the ability of keratinocytes to differentiate in culture,
cells were exposed for 2 days to medium containing CaCl2
solution. Panx1 protein levels were significantly reduced 2
days after calcium treatment (Figure 4d). However, both KO
and WT keratinocytes could start to differentiate in vitro,
as the differentiation marker involucrin was significantly
increased in both groups of keratinocytes (Figure 4e). There
were no apparent differences between WT and KO cells in the
levels of CK14, a marker of basal keratinocytes (Figure 4e).
To test whether the Panx1 present in these primary keratino-
cytes was forming active channels at the cell surface, we
performed a sulforhodamine B dye uptake assay as described
earlier by our group (Celetti et al., 2010). WT keratinocytes
could readily uptake dye, whereas KO cells exhibited
significantly reduced dye uptake. Dextran-rhodamine, which
is too large to pass through pannexin channels, did not enter
the cells, indicating that the cells were healthy and the plasma
membrane was intact (Figure 4f). All dye uptake assays were
performed in the presence of physiological levels of calcium
and magnesium to minimize any potential uptake due to
calcium-gated connexin hemichannels.
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Panx1 KO–derived primary dermal fibroblasts proliferate less
than WT fibroblasts and have reduced dye uptake capabilities
Primary dermal fibroblasts from WT neonatal mice abundantly
express Panx1 (Figure 5a). KO-derived fibroblasts grew faster
than WT control fibroblasts as revealed by growth curve
analysis (Figure 5b). This difference in growth was due to
proliferation and not due to decreased apoptosis, as shown by
differential labeling of nuclei with the proliferation marker
phospho-histone 3 (Figure 5c) and by apoptotic nuclei labeled
with Apoptag (TUNEL assay, Figure 5d). There was no
significant difference between WT and KO fibroblasts in the
total migrated distance after a scratch wound assay in vitro
(Figure 5e).
Similar to primary keratinocytes, WT primary dermal
fibroblasts were also capable of sulforhodamine B dye uptake
(Figure 5f), indicating that there were functional channels
present at the cell surface. Panx1 KO fibroblasts showed
significantly reduced dye uptake, and dextran rhodamine
controls were again negative (not shown). The Panx1 blocker
probenecid (PBN) had a dose-dependent response in the
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Figure 1. Panx1 decreases in aging skin and is absent in Panx1 knockout (KO)–derived tissues. (a) Western blots and (b, c) immunohistochemistry revealed that
Panx1 is elevated in neonatal skin and it decreases with aging. Cell surface localization of Panx1 in the basal epidermal keratinocytes and hair follicle
cells (solid arrows) is prevalent in 1-day-old skin (b) but is reduced 4 days after birth (c) and in differentiated keratinocytes (*). (b) Panx1 is also expressed in
dermal fibroblasts (open arrows) of neonatal skin. (d) Western blots of protein lysates from Panx1 KO tissues, revealed no expression of Panx1 compared with
wild type (WT). (e) qPCR of transcripts from brain and thymus confirmed the absence of Panx1 mRNA in the KO mice. (f) Panx1 is absent in dorsal skin
of KO mice. (g) The B43-kDa isoform of Panx3 is highly upregulated in 4-week-old Panx1 KO mouse skin and, to a lesser extent, in adult skin, whereas
theB70-kDa band of Panx3 does not change. Student’s t-test, N¼4, Po0.0001 or Po0.05. Bars ¼ 20mm. Blue, nuclei. Protein sizes in kDa. Gly0, 1, 2 represent
Panx1 bands with different levels of glycosylation. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was used as loading control.
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inhibition of dye uptake by WT fibroblasts but had no added
blocking effect on dye uptake from KO cells (Figure 5f and g).
Contractile properties of Panx1 KO–derived dermal fibroblasts
are reduced, and they do not increase smooth muscle actin in
response to TGF-b stimulation
To test whether Panx1 KO–derived dermal fibroblasts were
able to differentiate into myofibroblasts and efficiently con-
tract a free-floating collagen gel, we seeded equal numbers of
WT and KO fibroblasts into collagen lattices. The gel surface
area was measured for 96 hours. A significant decrease in
contraction was observed with KO-derived fibroblasts at all
time points (Figure 6a). This decrease was comparable to that
observed with WT-derived fibroblasts and subjected to the
Panx1 blocker PBN (Figure 6b). A dose-dependent response
was evident with 0.5 or 1 mM PBN, indicating that the channel
blocker had an effect on the contractile properties of the
Panx1-rich WT fibroblasts. Control gels without cells or
without serum showed no significant contraction as expected,
suggesting that the contraction is a mechanistic effect of the
myofibroblasts (Figure 6b).
Mouse dermal fibroblasts tend to spontaneously differentiate
when plated on hard surfaces or on collagen-coated plastic
dishware (Elliott et al., 2012). Both WT and KO dermal
fibroblasts had some level of differentiation and expressed
basal levels of smooth muscle actin (a-SMA) as seen on both
western blots and immunofluorescence (Figure 6c and d).
However, WT fibroblasts responded to the addition of TGF-b
by increasing the levels of a-SMA, a necessary step in normal
differentiation into contractile myofibroblasts. On the other
hand, Panx1 KO fibroblasts failed to further respond to TGF-b
maintaining the same levels of a-SMA, consistent with their
inability to fully contract (Figure 6a). Morphologically, KO
fibroblasts did not respond to TGF-b stimulation, whereas WT
fibroblasts acquired a contractile myofibroblast morphology
after stimulation (Figure 6d).
DISCUSSION
Normal skin development requires a carefully orchestrated set
of events involving different cell types derived from the
ectoderm and the mesenchyme. We have previously demon-
strated that Panx1 is expressed as early as day E13.5 in the
developing epidermis and dermis (Celetti et al., 2010). In
neonatal skin, Panx1 is highly expressed in keratinocytes,
fibroblasts, and hair follicle cells. In basal keratinocytes and
hair follicles, Panx1 is expressed at the cell surface in a profile
reminiscent of previously reported ectopic expression in
reference cells (Boassa et al., 2007; Penuela et al., 2007). As
keratinocytes differentiate and move upwards in the epidermal
layer, their Panx1 expression decreases and localizes to
intracellular compartments. On the basis of our previous
work (Penuela et al., 2009) and other reports (Boassa et al.,
2007), we would predict that the most complex glycosylated
form of Panx1 (Gly2) would be more prevalent at the cell
surface, whereas Gly1 and Gly0 would be more abundant
intracellularly. The change in Panx1 expression was
recapitulated in vitro when Panx1-rich primary basal
keratinocytes were induced to differentiate in the presence
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of calcium, and began to decrease their Panx1 expression
while increasing expression of involucrin, a differentiation
marker. However, Panx1 KO–derived primary keratinocytes
were still able to differentiate, so Panx1 may not be required
for initiating this process. Panx1 is important for proper skin
architecture, as Panx1 KO skin tends to have a thinner dermal
area than WT mice. This may be due to the effect of Panx1
deletion not only on the keratinocytes but also on the dermal
fibroblasts that appear to show dysregulated proliferation and
differentiation. As skin ages, Panx1 expression decreases in all
layers of the skin, indicating that this channel protein is
needed early on in development but is downregulated as skin
matures. This is similar to earlier reports of Panx1 expressed at
high levels in the embryonic and young neonatal rat brain that
significantly decline in adult rat brain (Vogt et al., 2005). Only
when the skin is challenged with an injury is Panx1 again
needed at the wound site, with expression peaking around day
6 after surgery but returning to basal expression levels typical
of adult mouse skin once the wound is healed.
The thinner dermal area seen on KO mouse skin appears to
be offset by an increase in the hypodermal fat area, which
may simply occur as a response to the need to maintain a
thermal balance of the thinner skin. Alternatively, the increase
in hypodermal fat could be due to potential changes in
hormone levels as has been reported for male mice with
low testosterone (Azzi et al., 2005), or other possible changes
in adipocyte regulation that move beyond the scope of this
study.
Similarly, without challenge, KO mice of different ages
seem to have no overt skin phenotypes other than the changes
in thickness seen under histological observations. This may be
explained in part by the upregulation and potential compen-
sation of Panx3 in KO skin of Panx1-null mice, particularly at
early stages when Panx1 would be needed for proper devel-
opment. However, upon injury of the dorsal skin at 12 weeks
of age, the lack of Panx1, even in the presence of Panx3
expression in the skin, results in significant delays in wound
healing, and after wound closure the scars that remain on the
KO skin are highly fibrotic. We observed a significant
difference between WT and KO skin in all phases of wound
healing. Early stages of wound healing could involve pannex-
ins due to a compromised inflammation response at days 1–3.
Panx1 has been reported to have a role in the inflammasome
(Silverman et al., 2009), is known to be expressed in
macrophages (Pelegrin and Surprenant, 2006), and could
very likely be involved in the signaling process of immune
cells for phagocytic clearance of apoptotic cells (Chekeni
et al., 2010). The granulation or proliferation phase is also
significantly delayed in which both Panx1-rich keratinocytes
and dermal fibroblasts have a major role (Gurtner et al., 2008).
Here, the deletion of Panx1 dysregulates migration of
keratinocytes and increases proliferation of dermal
fibroblasts, and these effects may be due in part to a lack of
ATP release via Panx1 channels present in these two cell
types. ATP released from Panx1 channels could potentially act
on purinergic receptors to activate downstream signaling that
affects proliferation, differentiation, and apoptosis of different
skin cell types, as reviewed by Burnstock et al. (2012). ATP
released in response to mechanical stimulation and cell
damage is involved in proper wound healing (Wang et al.,
1990), hence we could speculate that the complex of Panx1
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and purinergic receptors orchestrates the proper signaling
cascade needed for the healing response.
In addition, KO fibroblasts proliferate more in vitro, and can
migrate as well as the WT fibroblasts, but we hypothesize that
once at the site of injury, they cannot fully respond to TGF-b for
proper differentiation into a-SMA-enriched myofibroblasts that
serve to contract the wound (Desmouliere et al., 1993; Tomasek
et al., 2002). This lack of differentiation could be due to the
absence of ATP release needed for the proper differentiation and
contraction of fibroblasts (Ehrlich et al., 1986; Dolmatova et al.,
2012) or due to other molecules that may pass through the
channel. Some Panx1 channel-independent functions are also
possible, such as direct binding of the C-tail of Panx1 to actin
(Bhalla-Gehi et al., 2010). However, as PBN, although an
imperfect channel blocker (Silverman et al., 2008), seems to
block the dye uptake function in WT fibroblasts and mimics the
contraction impairment exhibited by KO fibroblasts, the channel
function of Panx1 is likely involved. The last phase of wound
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healing, known as tissue remodeling (Singer and Clark, 1999)
may also be compromised in the absence of Panx1 as KO scars
show increased fibrosis. Fibrotic and hypertrophic scars are
characterized by the excessive production of collagen and other
extracellular matrix components by the proliferating fibroblasts
that are not correctly remodeled, as is the case of keloid scars
(Tredget et al., 1997). Fibrotic scars could be explained by
increased proliferation of the KO fibroblasts at the wound site,
but also may be due to defects in extracellular matrix
remodeling and collagen reabsorption (Gurtner et al., 2008).
Collectively, we have shown that Panx1 has a key
role in proper skin development and its expression is not
needed in aging skin, unless there is an injury that requires its
upregulation. In keratinocytes and dermal fibroblasts,
Panx1 is required for proper migration and differentiation as
KO fibroblasts do not respond to TGF-b by increasing
a-SMA to form fully differentiated myofibroblasts that
can contract properly and aid wound closure. Panx1 may
be a new target for wound-healing treatments and
re-epithelialization.
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proliferation was confirmed by quantification of nuclei, stained with phospho-histone 3 (pHis3), N¼ 3, Po0.001. (d) Apoptag labeling (TdT terminal
deoxynucleotidyl transferase) of nuclei undergoing apoptosis showed no difference between WT and KO primary fibroblasts. (e) Scratch wound experiments
revealed that Panx1-null primary fibroblasts had no significant difference in migration compared with WT controls. N¼5, P40.05. (f) Sulforhodamine-B dye
uptake in Panx1 KO–derived primary cells was reduced under conditions of physiological calcium and mechanical stimulation when compared with WT controls.
WT fibroblasts responded in a dose-dependent manner to probenecid (PBN) inhibition of dye uptake, whereas the Panx1 blocker had no further inhibitory effect on
dye uptake in KO-derived cells. Po0.05, N¼ 4. Error bars indicate SEM (NS, not significant).
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MATERIALS AND METHODS
Detailed methods in Supplementary Section online.
Ethic statement and animals
Animal experiments were approved by the Animal Use Subcommittee
of the University Council on Animal Care at Western University.
Panx1 KO mice were a kind gift from Dr Vishva Dixit at Genentech
(San Francisco, CA) and were described by Qu et al. (2011). WT mice
of the C57BL/6N strain were from Charles River Canada (Saint-
Constant, PQ).
Western blots
Western blots of tissues and primary cell lysates were performed as
described in the study by Penuela et al. (2007, 2009). Panx1 and
Panx3 antibodies used (specific to the C terminus) were described in
the study by Penuela et al. (2009).
Immunolabeling
Coverslips with primary cells were fixed in either methanol acetone
or 10% neutral buffered formalin and immunolabeled with primary
antibodies as described previously (Penuela et al., 2007). For
proliferation assays, cells were labeled with the M-phase-specific
marker phospho-histone 3 (Millipore, Billerica, MA). For apoptosis
assays, cells were labeled following the Apoptag Fluorescein kit
instructions (Millipore) and nuclei were stained with Hoechst 33342.
Immunolabeling of dorsal skin samples was performed as described
in the study by Celetti et al. (2010). For histology assays,
parallel tissue sections were stained with hematoxylin/eosin. Images
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Figure 6. Contractile properties of dermal fibroblasts are compromised upon Panx1 deletion. (a) In a collagen lattice contractility assay, knockout (KO) dermal
fibroblasts embedded in free-floating collagen gels contracted significantly less than those embedded with wild-type (WT) fibroblasts (two-way ANOVA, N¼ 6, n¼36,
Po0.001) over 4 days. Gels without cells did not contract. (b) Images in a and b are representative of gels at the 96hours time point. WT fibroblasts in a similar time
course contractility assay exposed to 0.5 or 1.0mM of the Panx1 blocker probenecid (PROB) had reduced contractility in a dose-dependent manner (two-way ANOVA,
N¼ 6, n¼ 36, Po0.001 ). Gels without cells or with cells but no fetal bovine serum (FBS) had no significant gel contraction. Bars: SEM. (c) Fibroblasts derived from KO
mice neonatal skin do not respond to the addition of TGF-b1 (NS, not significant), whereas WT fibroblasts respond by increasing the expression of a-smooth muscle actin
(SMA; two-way ANOVA, N¼ 3, Po0.05). In two-dimensional culture, WT fibroblasts in the presence of TGF-b1 can change morphology by differentiating into
contractile myofibroblasts, whereas KO fibroblasts do not change cell morphology (d). SMA, red. Nuclei, blue. Bars ¼ 20mm. b-Tubulin was used as a loading control.
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were collected using a Leica DM IRE2 inverted epifluorescence
microscope as described in the study by Churko et al. (2011a).
ImageJ was used to determine the dermal area (epidermis and dermis)
as well as the hypodermal area (area between dermis and panniculus
carnosus). All statistical analyses were performed using GraphPad
v.4.1.
Primary keratinocyte and dermal fibroblast cultures
Neonatal dorsal skin was dissected from KO and WT pups. After
disinfection, the skin was processed either for primary keratinocyte
extraction and differentiation following the protocol described in the
study by Churko et al. (2012), or for extraction of dermal fibroblasts
and TGF-b differentiation as reported by Churko et al. (2011b).
Quantitative PCR
Total RNA was extracted with Qiagen RNeasy kits (Qiagen, Toronto,
ON, Canada) from brain and thymus dissected from 7-week-old
females from WT and Panx1 KO genotypes. Using the RevertAid H
minus, first-strand cDNA synthesis kit from Fermentas (Burlington,
ON, Canada), total RNA was used to generate the cDNA template.
Panx1 transcript levels were determined using mouse Panx1-specific
primers (forward: 50-ACAGGCTGCCTTTGTGGATTCA-30 and
reverse: 50-GGGCAGGTACAGGAGTATG-30) for qPCR amplification
with iQ SYBR green Supermix (Bio-Rad, Mississauga, ON, Canada) in
a Bio-Rad CFX96 real-time system. Results were normalized to b-2
microglobulin expression.
Cell growth and migration assays
Primary cells were evaluated in a growth curve assay as described
before (Churko et al., 2011b, 2012). Scrape wounding migration
assays were performed as described by Churko et al. (2011b).
Dye uptake assays
Primary cells were subjected to dye uptake assays under physiological
calcium as reported by Celetti et al., (2010) and Penuela et al. (2012).
PBN (Sigma, Oakville, ON, Canada) inhibition of dye uptake was
done at 0.2 mM or 1.0 mM PBN, with pre-incubation at 37 1C in
growth media for 1 hour. All dye uptake solutions and washes
contained the same dose of PBN. Controls were performed using
the vehicle solvent (D-PBS with calcium and magnesium, pH 7.4,
Invitrogen, Burlington, ON, Canada).
Wound healing
Twelve-week-old male mice (WT and KO) were anesthetized with
isoflurane gas and dorsal skin incisions were performed and evaluated
as described by Churko et al. (2011b).
Collagen gel contractility assay
Free-floating collagen gels were prepared from primary mouse
fibroblasts isolated from six wild-type mice and six Panx1 KO mice.
This technique has been described elsewhere (Grinnell et al., 1999;
Ngo et al., 2006; Kelly et al., 2012). For drug-treated gels, the
pannexin-1 inhibitor probenecid (Silverman et al., 2008) was added
to the cell suspensions and culture media to give a final concentration
of 0.5–1 mM.
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